FRONTAGE News

Haitong International: Maintaining Fangda Holdings (01521)'s “superior to market” rating target price reduction of 44% to HK$1.89

Zhitong FinanceApr 18 09:51

Fangda Holdings (01521.HK): Short-term fluctuations in performance are optimistic about the company's long-term steady development

海通國際Apr 17 00:00

Fangda Holdings (1521.HK) Updated Report: 2023 performance falls short of expectations and still faces challenges in the short term

中泰國際Apr 3 00:00

China-Thailand International: Reiterating that Fangda Holdings' (01521) “buy” rating target price fell to HK$3.15

Zhitong FinanceOct 28, 2022 15:00

Fangda Holdings (1521.HK): Good performance in the first three quarters of 2022

中泰國際Oct 27, 2022 00:00

Fangda Holdings (1521.HK): The results for the first half of the year slightly exceeded expectations

中泰國際Aug 26, 2022 00:00

Fangda Holdings (1521.HK): Integrated drug research and development improvement performance is expected to continue to grow

國元國際Apr 11, 2022 00:00

Fangda Holdings (1521.HK): 2021 profit margins are slightly dragged down by new business and medium-term prospects are good

中泰國際Mar 31, 2022 00:00

Fangda Holdings (01521.HK): high annual performance growth and continuous upgrading of the global one-stop platform

興業證券Mar 30, 2022 19:11

Fangda Holdings (01521.HK) Annual Report Review: Integrated Formation Is Optimistic About Strengthening Collaboration in '22

浙商證券Mar 29, 2022 00:00

Fangda Holdings (1521.HK): Accelerating integration and extremely cost-effective CXO targets

浙商證券Dec 30, 2021 00:00

Zheshang Securities: optimistic that the CXO rebound window is coming

浙商證券Dec 29, 2021 10:58

Focus on investment opportunities in the pharmaceutical industry during the Q3 performance disclosure period

安信國際Oct 21, 2021 10:48

Fangda Holdings (01521.HK): software and hardware capabilities continue to strengthen performance and high growth can be expected

興業證券Aug 30, 2021 00:00

Fonda Holdings (1521.HK): performance is expected to maintain rapid growth

中泰國際Aug 27, 2021 00:00

Fangda Holdings (1521.HK): the new layout accelerates the underestimation of landing and reiterates its recommendation.

浙商證券Jul 31, 2021 00:00

Fangda Holdings (1521.HK): Acquisition of QUINTARA's business, doubles the volume of integration and further accelerates

浙商證券Jun 28, 2021 00:00

First coverage by Fangda Holdings (1521.HK): Upstart in the biopharmaceutical CXO industry with a strong shareholder background

中泰國際Jun 17, 2021 00:00

Fangda Holdings (1521.HK): Strong recovery in performance and high growth is expected to continue in the future

國元國際Apr 14, 2021 00:00

Fangda Holdings (1521.HK): The business has fully recovered endogenous growth and the results of external mergers and acquisitions have been remarkable

安信國際Mar 30, 2021 00:00